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Background
Duchenne (DMD) and Becker (BMD) muscular dystrophy
(MD) are characterized by progressive peripheral muscular
damage. The cardiac involvement is high and often com-
plicated by severe heart failure and high mortality. Cardio-
vascular magnetic resonance (CMR) can identify early
stages of cardiomyopathy, as presence of myocardial fibro-
sis (MF). Several studies have shown negative correlation
between creatinophosphokinase (CPK) levels and worst
stages of peripheral muscular dystrophy, but have not
evaluated their possible association with myocardial
damage. Our objective was to investigate CPK levels and
magnitude of myocardial damage in patients with MD.
Methods
We analyzed 70 pts DMD and 6 BMD with confirmed
MD. All patients underwent cine-MR with SSFP sequence
for left ventricle (LV) ejection function (EF) evaluation
and late gadolinium enhancement (LGE) for MF detection.
LV volumes and function were measured by Simpson’s
method on the short-axis images. MF was measured as
the area with signal intensity above 5 standard deviation of
mean normal myocardium and expressed as percent of LV
mass. All analyses were performed using CVi42 software
(Circle CVi, Calgary, CA). Comparison between groups
was made using the unpaired t test and Mann-Whitney
test for continuous variables with normal and non-normal
distribution, respectively. To multivariate analysis of vari-
ables measured at different scales was performed a stan-
dardized variable, each rescaled to have a mean of zero
and a standard deviation of one. Correlation analysis was
performed using the Spearman correlation coefficient. All
statistical analyses were performed using Stata version 12
(StataCorp). A 2-tailed P value < 0.05 was considered
significant.
Results
Baseline characteristics are shown on Table 1. Standar-
dized data for age and for LVEF by CMR are shown in
Figure 1. Thirteen patients (17.1%) presented LVEF dys-
function (LVD) and, in comparison with patients with nor-
mal function, were significantly older (19.2 vs. 11.8 years,
p<0.001), with higher CK levels (11552.7 vs 2682.3,
p<0.001), lower LVEF (36.4% vs. 58.3%, p<0.001) and MF
as percent of LV mass (30.0% vs 8.6%, p<0.001). LVEF
showed moderate correlation with CK levels (r=0.479,
p<0.001), moderate and inverse correlation with age (r=-
0.590, p<0.001), and good and inverse correlation with MF
(r=-0.669, p<0.001). Additionally, after using multivariable
logistic regression, age, CK levels and MF continued to be
independent variables for predicting LVD (LVEF < 50%).
Conclusions
In this group of MD patients, we have demonstrated an
inverse correlation between CK levels and extent of
myocardial fibrosis standardized by age and left ventri-
cular ejection fraction. Moreover, independent predic-
tors of left ventricular dysfunction were found to be:
age, CK levels and myocardial fibrosis extent.
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Table 1 Baseline characteristics of patients with muscular dystrophy.
All (n=76) Normal LVEF (n=13) LVD (n=13) p
Age, years ± SD 13.0 ± 4.4 11.8 ± 3.3 19.2 ± 3.9 <0.001
BMI, kg/m2 ± SD 19.6 ± 4.4 18.9 ± 4.1 22.9 ± 4.1 0.002
CK, ± SD 10035.4 ± 7305.6 11552.7 ± 7040.9 2682.4 ± 2603.4 <0.001
LVEDVI, ml ± SD 70.7 ± 32.7 62.5 ± 17.5 110.5 ± 55.1 <0.001
LVESVI, ml ± SD 33.8 ± 28.2 25.6 ± 7.9 73.7 ± 50.5 <0.001
LVEF, % ± SD 54.5 ± 10.2 58.3 ± 5.2 36.4 ± 9,5 <0.001
LV mass, g ± SD 80.8 ± 40.3 70.8 ± 29.6 128.9 ± 50.9 <0.001
Fibrosis, % ± SD 12.3 ± 13.5 8.6 ± 9.8 30.0 ± 14.9 <0.001
Figure 1 Standardized data of CK and fibrosis by CMR for Age (A) and LVFE (B).
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